John Matthew Jasinski, PA-C

John Jasinski practices at Illume Fertility in Norwalk, Connecticut.

John Jasinski's NPI, 1598781791, was assigned on July 14, 2006. John Jasinski holds Connecticut license 001206.

John Jasinski's primary practice is Illume Fertility, at 761 Main Ave, Norwalk, CT 06851. The practice phone is (203) 750-7400.

John Jasinski's primary practice is Illume Fertility in Norwalk, Connecticut. The medical group on file is Schweiger Dermatology Group. Dmand AI also links John Jasinski to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where John Jasinski practices, 3 sites in all. Vendor and product names are available with a free account.

Medical is John Jasinski's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. John Jasinski is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). John Jasinski is licensed in Connecticut.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cold sores or genital herpes, contact dermatitis, corns and calluses, facial skin infection and head wound among the conditions John Jasinski treats.

CMS data shows 3,626 Medicare services from John Jasinski across 21 procedure codes in 2024, for 760 Medicare patients. Medicare paid $141,437 for them. Every service was in an office.

CMS counts 760 Medicare patients who saw John Jasinski in 2024. The largest group is 65 to 74, with 351 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 9% are also on Medicaid. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts John Jasinski's median patient age at 56, with 43% women.

In 2024, John Jasinski wrote 1,282 Medicare Part D claims for 513 patients. 90% of them were for generic drugs. CMS names the drug for 1,134 of them, across 25 drugs with 11 or more claims each, at $205,367 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 98 out of 100 for John Jasinski for performance year 2024, reported as part of a group. John Jasinski accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 362 general payments to John Jasinski from 19 drug and device companies in 2025. Speaker and faculty fees make up the largest share, 79% of the total. Janssen Pharmaceuticals, Inc paid the most, $19,690.

John Jasinski is a member of AAPA and SDPA.